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ABSTRACT 24 
The study of protein glycosylation can be regarded as an intricate but very important 25 
task, making glycomics one of the most challenging and interesting, albeit under-26 
researched, W\SH RI ³omics´ science. Complexity escalates remarkably when 27 
considering that carbohydrates can form severely branched structures with many 28 
different constituents, which often leads to the formation of multiple isomers. In this 29 
regard, ion mobility (IM) spectrometry has recently demonstrated its power for the 30 
separation of isomeric compounds. In the present work, the potential of traveling wave 31 
IM (TWIMS) for the separation of isomeric glycoconjugates was evaluated, using 32 
mouse transferrin (mTf) as model glycoprotein. Particularly, we aim to assess the 33 
performance of this platform for the separation of isomeric glycoconjugates due to the 34 
type of sialic acid linkage, at the intact glycoprotein, glycopeptide and glycan level. 35 
Straightforward separation of isomers was achieved with the analysis of released 36 
glycans, as opposed to the glycopeptides which showed a more complex pattern. 37 
Finally, the developed methodology was applied to serum samples of mice, to 38 
investigate its robustness when analysing real complex samples. 39 
 40 
41 
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1. Introduction 42 
Glycosylation is by far one of the most common and complex posttranslational 43 
modifications, with more than half of all secretory and cellular proteins being 44 
glycosylated [1±3]. Carbohydrates enhance the functional diversity of proteins, but they 45 
can also define their destination or elicit an immune response. The presence of glycans 46 
in the surface of eukaryotic cells is vital, as they take part in important cellular events, 47 
such as cell±cell interactions and receptor recognition [4]. Notwithstanding its 48 
importance and the major role of glycosylation in a multitude of biological processes 49 
[5±7], the analysis and characterization of carbohydrates is usually difficult due to their 50 
inherent complexity - the main reason why advances in glycomics have been scarcer 51 
compared to other ³omicV´ sciences [8,9]. Very often, in contrast to more linearly 52 
assembled biological molecules such as proteins or oligonucleotides, carbohydrates can 53 
form complex structures, severely branched, with many monosaccharide constituents, 54 
which usually results in a multitude of isomers [10]. 55 
Mass spectrometry (MS)-based techniques are the prime option for the characterization 56 
of glycoproteins, as reliable structural information can be obtained [7,11]. MS is 57 
frequently used in conjunction with chromatographic or electrophoretic separation 58 
techniques, as this allows high sensitivity profiling and accurate characterisation of 59 
heterogeneous glycan structures [12±14]. However, when analysing isomeric glycan 60 
structures, MS often fails to separate them [8,15±17], as they have identical mass and 61 
atomic composition. Some authors have suggested alternative strategies to separate 62 
isomeric glycoconjugates based on their derivatization, the use of capillary 63 
electrophoresis (CE) or hydrophilic interaction liquid chromatography (HILIC)[18±23]. 64 
But even then, derivatization protocols can be time-consuming, expensive or hinder the 65
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ionization of some glycans, or, in the case of CE or HILIC, the unambiguous 66 
identification is still impossible when different isomers coelute. Moreover, in the last 67 
few years, several tandem mass spectrometry (MS/MS) methods have been reported 68 
that allow the identification of glycan isomers and the characterization of their structure 69 
[24±26]. However, few authors have studied the fragmentation of glycans with different 70 
sialic acid linkages. Even then, distinguishing by MS/MS between isomeric glycans due 71 
to sialic acid linkage is not trivial and, quite often, is based on differences in the relative 72 
abundance of certain fragment ions [27,28]. Therefore, a straightforward technique that 73 
helps to separate and differentiate those isomeric compounds is much needed. 74 
In this regard, ion-mobility (IM) spectrometry coupled with MS has aroused some 75 
interest in the last years, not only in the glycomics field but also in other omics sciences, 76 
as a proficient analytical technique for the separation of isomeric compounds 77 
[3,8,10,15±17,29±31]. Ion mobility provides an additional dimension for the separation 78 
of compounds, where ions are not only separated due to their mass and charge, but also 79 
on the basis of their shape and size - thereby resolving ions that would be otherwise 80 
indistinguishable solely by MS, such as, for instance, isomers [32±36]. Particularly, IM 81 
measures the time (drift time) that a particular ion takes to cross a cell filled with an 82 
inert, neutral background gas (N2 and He are most commonly used) at a controlled 83 
pressure under the influence of a weak electric field. The drift time of a specific ion is 84 
mainly due to ion-gas collisions; therefore, ions are separated due to their ion-neutral 85 
collision cross-section (ȍUHODWHGWRWKHRYHUDOOVKDSHDQGWRSRORJ\RIWKHLRQ [32±36]. 86 
Small compact ions have the shortest drift times, i.e. they arrive first, as a result of their 87 
VPDOOHU ȍ 0RUHRYHU WKH KLJKHU WKH FKDUJH RI WKH LRQ WKH JUHDWHU WKH accelerating 88 
electric force, and therefore the more quickly the ion will cross the chamber. 89 
5 
 
Consequently, the drift time of an ion is often described as being determined by the 90 
collision cross-section-to-FKDUJHUDWLRȍ] [35]. When coupled on-line with MS (IM-91 
MS), ion mobility provides three-dimensional analytical information for each detected 92 
species, i.e. shape-to-charge, mass-to-charge and abundance, thus allowing reliable 93 
analyte identification. 94 
Nowadays, there are several IM methods next to the classical drift-time ion mobility 95 
spectrometry (DTIMS), such as field asymmetric waveform ion mobility spectrometry 96 
(FAIMS), but among them, traveling wave ion mobility spectrometry (TWIMS) is the 97 
one that has seen a major growth in the last years [37,38]. In TWIMS, ions are propelled 98 
thanks to a sequence of symmetric potential waves continually propagating through a 99 
cell, each ion with its own velocity, thus different species transit the cell in different 100 
times. One of the main advantages of TWIMS is that it disperses ion mixtures, allowing 101 
the simultaneous measurement of multiple species. This, in conjunction with a high 102 
sensitivity obtained when TWIMS is coupled to certain analyzers in MS, such as time-103 
of-flight (TOF), has made this platform an alluring option for structural analysis and 104 
isomer separation [38±40]. This platform, along with other IM methods, have been 105 
recently explored for the analysis of glycans or glycoconjugates by several authors 106 
[8,15,16,41±47].  107 
In this work, TWIMS combined with TOF-MS was used for the study of 108 
glycoconjugate isomers which differ in the type of sialic acid linkage, with mouse 109 
transferrin (mTf) as a model glycoprotein. Sialic acid, an important monosaccharide 110 
residue of complex type N-glycans, may form primarily two types of linkages: Į2-3 or 111 
Į2-6. We aim to assess the capacity of TWIMS-TOF-MS (from now on referred to as 112 
IM-MS) as an analytical platform to separate Į2-3 DQGĮ-6 isomeric glycoconjugates at 113 
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the intact glycoprotein, glycopeptide and glycan level. The developed methodology was 114 
also applied to serum samples of mice, to confirm its robustness when analysing real 115 
complex samples. 116 
  117 
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2. Materials and methods 118 
2.1 Chemicals 119 
All chemicals used in the preparation of buffers and solutions were of analytical reagent 120 
grade. Isopropanol (iPrOH), hydrochloric acid (HCl, 37% (w/v)), formic acid (FA, 98±121 
100%), ammonium acetate (NH4Ac, 98.0%) DQGJO\FLQH ZHUH VXSSOLHGE\122 
Merck (Darmstadt, Germany). CNBr-activated-Sepharose 4B was provided by GE 123 
Healthcare (Waukesha, WI, USA) and ³13-DOWHUQDWLYH´E\&DOELRFKHP (Darmstadt, 124 
Germany)6RGLXPFKORULGH1D&O'/-'LWKLRWKUHLWRO '77sodium 125 
cyanoborohydride (NaBH3CN), 2-PHUFDSWRHWKDQRO ȕ-ME), sodium dodecyl sulfate 126 
(SDS), iodoacetamide (IAA), ammonium hydrogencarbonate, sodium azide (NaN3, 127 
99.5%) water (LC-MS grade), acetonitrile (LC±MS grade) and mouse apotransferrin 128 
(mTf, reference: T0523) were supplied by Sigma±Aldrich (St. Louis, MO, USA) and 129 
7ULVK\GUR[\PHWK\ODPLQRPHWKDQH75,6E\-7%DNHU'HYHQWHU+ROODQG130 
Trypsin (Sequencing grade modified) was provided by Promega (Madison, WI, USA). 131 
RapiGest® from Waters (Bedford, MA, USA) was used to facilitate the enzymatic 132 
digestion. Goat polyclonal antibody against human transferrin (hTf) (immunogen 133 
affinity purified) was purchased from Abcam (Cambridge, UK). Human transferrin 134 
K7I DQG KXPDQ Į-1-acid glycoprotein (hAGP) were used as additional examples of 135 
other glycosylated glycoproteins and were also supplied by Sigma±Aldrich. 136 
2.2 Mice and induction of arthritis 137 
Wild-type (WT) mice were from Harlan Ibérica (Barcelona, Spain). All studies with live 138 
animals were authorized by the Institute of Parasitology and Biomedicine "López-139 
Neyra" (IPBLN) and Universidad de Cantabria Institutional Laboratory Animal Care 140 
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and Use Committees. For the induction of collagen-induced arthritis (CIA), 8-12 weeks-141 
old male mice were immunized as described elsewhere [48,49]. 142 
2.3 Purification of serotransferrin from mouse serum samples by immunoaffinity 143 
chromatography (IAC)  144 
In order to isolate mTf from the rest of serum proteins, an immunoaffinity (IA) 145 
purification was carried out using a cyanogen-bromide sepharose column where a 146 
polyclonal antibody against human transferrin (hTf) was bound, as detailed previously 147 
[50]. The IA procedure consisted of: first, a conditioning step with two washes of 10 148 
mM Tris-HCl; second, approximately 25 ɊL of serum were diluted 1:8 in 10 mM Tris-149 
HCl (pH 7.6-7.7) in order to improve antigen-antibody interaction, and passed through 150 
the column ten times. After washing with 10 mM Tris-HCl and 0.5 M NaCl (pH 7.6-151 
7.7), retained mTf was eluted with 100 mM glycine-HCl (pH 2.5). Eluted mTf was 152 
immediately neutralized with 0.5 M Tris. Afterwards, glycine-HCl buffer was 153 
exchanged for water by ultracentrifugation, using Microcon YM-10 (MW cut-off 10 154 
kDa, Millipore, Bedford, MA, USA). Then, samples were evaporated to dryness using a 155 
SpeedVacTM concentrator (Thermo Fisher Scientific, Waltham, MA, USA) and stored at 156 
-20ºC until use. Finally, the IA column was washed and stored in 10 mM Tris-HCl and 157 
0.01% (w/v) NaN3 (pH 7.6-7.7). 158 
2.4 Analytical approaches for mTf glycosylation study 159 
2.4.1 Intact glycoprotein analysis 160 
mTf standard ( ȝJ) was desalted using three different procedures: dialysis, size 161 
exclusion and ultracentrifugation. Briefly, in the first method, D-TubeTM dialyzers from 162 
Merck-Millipore were left in contact with 100 mM NH4Ac for 15 min. Afterwards, the 163 
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sample was placed into the dialyzer and left in contact with 500 mL of 100 mM NH4Ac 164 
for 2 h at 4ºC. Later, the buffer was renewed with 500 mL and the dialysis was allowed 165 
to continue for 2 more hours, repeating this process twice. Finally, the sample was 166 
carefully recovered and stored at -20ºC until analysis. Regarding the size exclusion 167 
procedure, the sample was desalted and the buffer exchanged using Micro Bio-SpinTM 168 
columns from BioRad (Hercules, California, USA) following the manufacturer 169 
instructions. Columns were centrifuged to remove the excess of packing buffer and 170 
washed three times with 500 ɊL of 100 mM NH4Ac. Finally, the sample was added and 171 
collected in a new tube after centrifugation. Lastly, the ultracentrifugation procedure 172 
was carried out using Microcon YM-10 (MW cut-off 10 kDa) to desalt and exchange 173 
the buffer of the sample. Filters were washed with 100 mM NH4Ac and centrifuged for 174 
10 min at 10000 g. Afterwards, the sample was added and washed with 50 ɊL of 100 175 
mM NH4Ac a total of 4 times, centrifuging each time for 10 min at 10000 g. Finally, the 176 
final volume was recovered in a new vial after centrifugation for 2 min at 1000 g, and 177 
reconstituted to the initial volume (25 ɊL). Centrifugation procedures were carried out 178 
in a MiniSpin® centrifuge (Eppendorf, Hamburg, Germany) at room temperature. In all 179 
cases, experiments with the standard glycoprotein were carried out in triplicate and 180 
intact mTf in 100 mM NH4Ac was injected directly into the mass spectrometer under 181 
non-denaturing conditions and detected in positive ion mode.  182 
2.4.2 Glycopeptide analysis 183 
mTf standard ( ȝJ) was reduced, alkylated and immediately subjected to trypsin 184 
digestion in the presence of RapiGest® as explained in previous work [51]. Briefly, a 185 
solution of 0.5 M DL-dithiothreitol (DTT) in 50 mM NH4HCO3 was added to an aliquot 186 
of mTf with 0.1% (w/v) RapiGest®. The mixture was incubated at 56ºC for 30 min and 187 
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then alkylated with 50 mM iodoacetamide (IAA) for 30 min at room temperature in the 188 
dark. Excess reagent was removed by ultracentrifugation with Microcon YM-10 189 
columns (Millipore, Bedford, MA, USA). The final residue was recovered from the 190 
upper reservoir and reconstituted with NH4HCO3 buffer with 0.1% RapiGest®. Trypsin 191 
in a 1:40 ratio was added and the mixture was incubated overnight at 37ºC. Afterwards, 192 
the surfactant was hydrolyzed to avoid MS incompatibilities as follows: formic acid 193 
(FA) was added to the digest to a final concentration of 5% (v/v) and the mixture was 194 
incubated in the digester at 37ºC for 30 min. Then, the solution was centrifuged to 195 
separate RapiGest® residues. mTf tryptic digests were stored at -20ºC until analysis. All 196 
the experiments with the standard glycoprotein were carried out in triplicate. 197 
For the analysis of glycopeptides, a Waters Nano ACQUITY UPLC® was used with a 198 
double binary gradient pump, using a peptide BEH C18 column (1.7 µm particle 199 
diameter, 130 Å pore, 100 x 0.1 mm length x ID; Waters). Experiments were performed 200 
at room temperature with gradient elution at a flow rate of 400 nL min-1. Eluting 201 
solvents were A: water with 0.1% (v/v) of formic acid (FA), and B: acetonitrile with 202 
0.1% (v/v) FA. Solvents were degassed by sonication (10 min) before use. The 203 
optimum elution program was: solvent B from 10 to 60% (v/v) within 20 min as linear 204 
gradient, followed by cleaning and re-equilibration steps of B: 60 to 100% (v/v) (5 205 
min), 100% (v/v) (5 min), 100 to 10% (v/v) (5 min) and 10% (v/v) (5 min). Before 206 
analysis, samples were filtered using a 0.22 Ɋm polyvinylidene difluoride centrifugal 207 
filter (Ultrafree-MC, Millipore, Bedford, MA, USA) centrifuging at 10,000 g for 4 min. 208 
Sample injection (300 nL) was performed with an autosampler refrigerated at 4ºC. 209 
Control of the instrument was performed using MassLynx 4.1 (Waters).  210 
2.4.3 Glycan analysis 211 
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IAC purified mTf or mTf standard (25 Ɋg) was reduced with 0.5% 2-mercaptoethanol 212 
(ȕ-ME) and 0.5% SDS in 50 mM NH4HCO3 (pH 7.6-7.7) and heated in a thermo block 213 
at 100 ºC for 30 min [19]. Once the sample was at room temperature, a volume of 50 214 
mM NH4HCO3 (pH 7.6-7.7) with 1% (v/v) of NP-40 alternative was added to obtain a 215 
ILQDO FRQFHQWUDWLRQ RI  6'6 DQG ȕ-ME in the sample. To release the N-glycans, 216 
ȝ/ RI 31*DVH )  8 VROXtion was added to the mixture, which was afterwards 217 
incubated at 37ºC for 18 h. Digestion was stopped by heating the sample in a thermo 218 
block at 100ºC for 5 min. Then, released glycans were isolated by solid phase extraction 219 
(SPE) using Hypercarb cartridges (25 mg, 1 mL volume, Thermo Fisher Scientific) and, 220 
subsequently, purified by ice-cold acetone precipitation following the procedure 221 
reported in [19] in both cases. Reduced glycans were diluted with 50:50 H2O/ACN with 222 
0.1% FA and directly analyzed by IM-MS in negative ion mode. All the experiments 223 
with the standard glycoprotein were carried out in triplicate. Mice derived transferrin 224 
glycan analysis was carried out in duplicate, including purification and release of 225 
glycans. 226 
2.5 Ion mobility-mass spectrometry 227 
For IM-MS analysis a Synapt G2 HDMS instrument from Waters was used. Samples 228 
were directly introduced into the mass spectrometer using home-made nano-229 
electrospray ionization (nano-ESI) gold-coated borosilicate capillaries; unless when 230 
analysed by nano-UPLC-IM-MS, in which case an in-line nano-ESI interface with 231 
commercially available coated needles was used. 232 
Spectra were acquired in positive mode for the analysis of intact glycoproteins and 233 
glycopeptides, and in negative mode for glycans, and conditions were optimized in each 234 
case. The voltages for spray capillary, sampling cone, trap collision energy (CE), trap 235 
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direct current (DC) bias and transfer CE were, respectively: intact glycoproteins, 1.4-1.6 236 
kV, 30 V, 4 V, 40 V and 0 V; glycopeptides, 1.5-1.7 kV, 50 V, 4 V, 20 V and 0 V; and 237 
glycans, 1.5 kV, 50 V, 4 V, 45 V and 0 V. 7KH³Wrap CE´YROWDJH was only increased to 238 
60 V when fragmentation of the glycopeptides was the goal. Mass spectrometer control 239 
and spectra processing were carried out using MassLynx 4.1 (Waters). 240 
The software IMoS [52,53], available for free at imospedia.com, was used for the 241 
theoretical calculations of the collision cross sections (CCS) of glycans, using their 242 
minimum energy structures. The online tool carbohydrate builder, available at 243 
glycam.org [54], was used to generate the required input for theoretical calculations. 244 
The tool allows building different glycan isomers based on monosaccharide unit and 245 
linkage type, and generates minimum energy structures.  246 
  247 
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3. Results and discussion 248 
3.1 Intact glycoprotein analysis 249 
It is well established that intact proteins can be analysed mainly in two different ways 250 
when using electrospray ionization: under denaturing or non-denaturing (i.e., ³native´) 251 
conditions. In the first case, the protein appears highly charged with a broad charge state 252 
distribution; thus, the separation of the different glycoforms is difficult. On the other 253 
hand, an advantage of native MS is that it strongly reduces charging, hence the different 254 
glycoforms can be more clearly resolved [55]. 255 
Using native MS in this work, the concentration of ammonium acetate and the nano-ESI 256 
source parameters were optimized to improve and obtain the best possible sensitivity 257 
and separation between mTf glycoforms in positive ion mode. Moreover, in order to 258 
obtain an acceptable separation between the several glycoforms, mTf was washed 259 
repeatedly with 100 mM NH4Ac to eliminate excipients and salts, and injected directly 260 
into the mass spectrometer without further separation. Without washing, no glycoform 261 
separation was observed whatsoever. Three methods were evaluated to desalt the 262 
glycoprotein: dialysis, size exclusion and ultracentrifugation, with the latter one giving 263 
the best results (see supplementary Figure S1). Afterwards, the drift times of intact 264 
glycoforms were determined by ion mobility. In Figure 1-a, the ion with charge +19 of 265 
mTf is shown, as well as the arrival time distributions (ATD) of different sections of 266 
this peak (Figure 1-a (i-v)), each corresponding to one intact glycoform of mTf). As can 267 
be observed in the ATD profiles, only one, relatively wide peak is obtained for each 268 
glycoform. Hence, these results imply that, at least for large glycoproteins with a low 269 
degree of glycosylation, the glycan part has barely any influence on the overall size of 270 
the whole molecule as the CCS appears virtually unaffected by glycosylation. hTf and 271 
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hAGP were also studied to see if the same behaviour was observed with other 272 
glycoproteins. Figure 1-b and 1-c show the separation between intact glycoforms in the 273 
MS spectra of hTf (for the ion with charge +19) and hAGP, respectively. As can be 274 
observed, the peak was better resolved for hTf, but no separation was observed for 275 
hAGP, as the number of glycoforms was considerably higher and the overlapping of 276 
several ion distributions was unavoidable. Moreover, one wide peak was observed again 277 
when the drift time of each section of the mass spectrum was measured for both 278 
glycoproteins. Regarding hTf, each section corresponded to one glycoform (Figure 1-b 279 
(i-iv)), whereas, in the case of hAGP, the resolution was not high enough to ensure that 280 
a selected region of the peak corresponded to one defined glycoform (Figure 1-c (i-v)), 281 
because of the high glycosylation degree of hAGP. The higher the m/z region of this 282 
peak however, the bigger the carbohydrate fraction is (usually meaning more complex 283 
and branched glycans). This is due to the fact that an increase of m/z within the same 284 
charge state can only be due to an increase in the number of glycan subunits of the 285 
carbohydrate fraction, as the polypeptide backbone remains unaltered. For the sake of 286 
consistency, we will refer to each section of the peak as glycoform, even if, as in the 287 
case of hAGP, they are not resolved. Interestingly, the drift time increased with 288 
increasing carbohydrate fraction, i.e. complexity and branching of the glycoforms, in all 289 
three cases (see Figure 1-a (i-v), 1-b (i-iv) and 1-c (i-v), type of glycoform indicated 290 
where possible). The relative drift time differences between glycoforms were higher in 291 
proteins with higher glycosylation content, as can be observed for hAGP (see Figure 1-292 
c). Moreover, if we compare the drift time between different glycoforms of mTf and 293 
hTf, the increase in drift time was more noticeable in hTf, as the percentage of 294 
glycosylation is slightly higher here in relation to the total protein mass. As Table 1 295 
shows, for the same relative increase in m/z, the relative drift time increase is higher for 296 
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hAGP, which demonstrates that for glycoproteins with a high percentage of 297 
glycosylation, differences in the glycosylation have a greater effect on the drift time of 298 
the whole molecule (i.e., they significantly alter the CCS of the whole glycoprotein). It 299 
could then also be conceivable to separate isomers due to the different sialic acid 300 
linkage (of the same glycoform) at the intact protein level if the glycan:peptide ratio was 301 
high enough. However, this option would not have been viable for all types of 302 
glycoproteins, thus, other alternatives were studied. 303 
3.2 Glycopeptide analysis 304 
As mTf only shows one glycosite at asparagine 494, only one glycopeptide is expected 305 
after tryptic digestion (N494 glycopeptide, peptide: NSTLCDLCIGPLK). However, with 306 
the direct injection of the digest, the N494 glycopeptide was not detected, hence, an 307 
additional separation before the MS was mandatory. In this regard, nano-UPLC was 308 
used as a separation technique prior to IM-MS detection, in order to separate the 309 
glycopeptide from the other peptides and simultaneously determine the drift time of the 310 
different glycoforms. Injection volume, flow rate and gradient were optimized to obtain 311 
the best sensitivity with a stable spray (see section 2.4, Materials and Methods). Table 2 312 
shows the detected glycoforms at the peptide level, their theoretical and experimental 313 
masses, mass error and observed charge states.  314 
Regarding the determination of the drift time of the different glycopeptide glycoforms, 315 
even though a range of different values for the wave velocity (WV) and wave height 316 
(WH) of the TWIMS device were tested, only one drift time value was observed. This 317 
suggests that no isomer separation was possible at this mobility resolution, which is 318 
probably due to the fact that the different isomers had similar CCS despite the distinct 319 
orientation of the sialic acid. Recently, Hinneburg et al. [15] and Guttman et al. [45] 320 
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also described this observation analysing glycopeptides directly by IM-MS. They 321 
observed no isomeric separation, unless fragmentation of the glycopeptide was carried 322 
out and one of the observed smaller fragments still contained the sialic acid. This 323 
fragment (obtained before the IM cell) had different drift times depending on the sialic 324 
acid linkage, because a change in the orientation of the sialic acid was more noticeable 325 
(i.e. the CCS was more affected) in a smaller analyte. We also tested this approach, by 326 
fragmenting the most intense glycopeptide glycoform (N(H5N4S2)STLCDLCIGPLK) 327 
before the IM cell. Figure 2-a shows the collision induced dissociation (CID) MS/MS 328 
spectrum for this glycoform. Several fragments were obtained, e.g., the 329 
glycolylneuraminic acid (S1) and H1N1 and H2N1 fragments. Among all the fragments 330 
however, H1N1S1 was the one that still retained the sialic acid linkage and had enough 331 
intensity to yield a good and accurate drift time measurement. Isomer separation was 332 
observed in the aforementioned glycan fragment. Specifically, as it is shown in Figure 333 
2-c, two drift time peaks were clearly observed at this m/z, which are postulated to be 334 
due to the sialic acid being Į2-6 and Į-3 linked. To confirm that the sialic acid is the 335 
monosaccharide that affects the CCS of the fragment the most, the ATD of the fragment 336 
H1N1 is shown in supplementary Figure S2-c. In this case, we only observed one drift 337 
time, which demonstrates that it is the sialic acid which causes observable CCS 338 
differences seen as two different drift times of the fragment H1N1S1.  339 
Moreover, in order to confirm that the distinct drift times observed for the glycan 340 
fragment could be due to different sialic acid linkages, the theoretical CCS of the 341 
H1N1S1 isomers were calculated. The obtained CCS values can be found in Table 3. 342 
The CCS for the two H1N1S1 were different enough to be separated by IM. Taking into 343 
account the CCS values of Table 3, the more prominent, lower drift time peak (i.e., 344 
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lower CCS) should correspond to the Į-6 glycan, whereas the second peak represents 345 
the Į-3 glycan. 346 
Our results are in accordance with those obtained by Hinneburg et al. [15], who, using 347 
modelling, drew the same conclusions. This is also in agreement with Guttman et al. 348 
[45], who found that biantennary glycoforms showed lower content of Į2-3 sialylation. 349 
In our case, the percentage of Į2-3 glycan was approximately 14% (taking into account 350 
the measured area of each drift time peak, see Figure 2-c). However, this ratio can vary 351 
depending on the glycoprotein studied [45]. This glycopeptide approach, through the 352 
analysis of the fragment H1N1S1, gave valuable information about the content of each 353 
type of sialic acid as the fragment H1N1S1 came from both branches of the H5N4S2 354 
glycopeptide (we did not detect any fragment with only one antenna remaining (H3N3 355 
or H3N3S1), suggesting that both antennas might indeed be fragmented). This relevant 356 
information could permit, in the future, to correlate changes in protein sialylation with 357 
specific disease biomarkers which involve protein glycosylation, such as, e.g., in cancer 358 
or inflammation. 359 
 360 
3.3 Glycan analysis 361 
Finally, we proceeded with the study of the enzymatically released glycans using 362 
PNGase F. Different solvents were tested to obtain the best spray and ionization yield, 363 
and a slightly superior glycan signal was obtained at 50:50 H2O:ACN with 0.1% FA. 364 
Table 4 shows the detected mTf glycans along with their theoretical and experimental 365 
masses, mass error and observed charge states. In Figure 3 the ATD profile of H5N4S2 366 
glycans at different values of WV and WH is shown. Two peaks are observed which are 367 
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believed to correspond to two different isomers of the glycan H5N4S2, in analogy to the 368 
previously obtained results (Figure 2-c) with the fragment H1N1S1 of the glycopeptide 369 
N(H5N4S2)STLCDLCIGPLK. Fine tuning of the IM parameters was mandatory in 370 
order to resolve both drift time peaks. A WV value of 450 m s-1 and WH of 25 V was 371 
selected as optimal for the analysis of all mTf glycans. It is worth mentioning that in 372 
this case, glycans were analyzed in negative mode and, as can be observed in Figure 3, 373 
the first isomer was clearly the less abundant one. This is in contrast to the glycopeptide 374 
analysis which was done in positive mode, where the less abundant isomer was the 375 
second one. This could be due to the fact that both molecules were, actually, quite 376 
different - specifically, the glycan had eleven monosaccharide units, as opposed to the 377 
fragment observed in the glycopeptide analysis which had only three. With regard to 378 
other glycans, three different peaks, i.e., three drift times, were observed for H6N5S3 379 
(see supplementary Figure S3-c), albeit separation was slightly worse than observed for 380 
H5N4S2. H5N4S1 on the other hand only showed one wide peak (see supplementary 381 
Figure S3-d), implying that only one glycan isomer exists or that the different isomers 382 
have similar CCS, and IM is not able to distinguish them (as the absence of other drift 383 
time peaks does not preclude the presence of other isomers). It is also worth pointing 384 
out that when the glycan contained a fucose unit, the isomeric separation was somewhat 385 
hampered, as observed in supplementary Figure S3-b. We reckon that the addition of 386 
one extra monosaccharide unit might affect the global CCS of the glycan, and as the 387 
whole glycan is bigger, a small variation in the orientation of the sialic acid is less 388 
noticeable.  389 
To confirm that separation of isomeric glycans due to the sialic acid linkage was also 390 
possible with other glycoproteins, hAGP was also digested with PNGase F and the 391 
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released glycans analysed by IM-MS. Separation of isomeric glycans was achieved, 392 
seemingly obtaining the same results as with mTf. As an example, the arrival time 393 
distributions of the H5N4S2 and H6N5S2 glycans are shown in supplementary Figure 394 
S4. As can be seen, two drift time peaks were obtained for the H5N4S2 glycan and 395 
three peaks for H6N5S3, albeit separation was poorer in both cases when compared to 396 
mTf.  397 
Moreover, to confirm that ion mobility separation of these possible isomers is due to 398 
different sialic acid linkages, Table 3 shows the theoretical CCS values of the four 399 
possible isomers for the glycan H5N4S2. The differences between these calculated 400 
values suggest that the observed ion mobility peaks could be due to isomeric glycans 401 
with different types of sialic acid linkage. With the knowledge of theoretical CCS, and 402 
the DEXQGDQFH RI WKH Į- +16 IUDJPHQW EHLQJ ORZHU WKDQ Į-6 (based on 403 
fragmentation of the H5N4S2 glycopeptide, see above), some conclusions can be 404 
drawn. We reckon that the presence of the isomer with two sialic acids Į2-3 can be 405 
discarded and that the two peaks observed must correspond to the isomers with higher 406 
content in Į2-6, that is, the isomer with two sialic acids Į2-6 and the isomer with one 407 
sialic acid Į2-6 and one Į2-3 (although we cannot specify the branch where each sialic 408 
acid is located). Alternative approaches for the study of isomeric glycoconjugates, for 409 
instance using specific sialidases [18], would however allow to obtain complementary 410 
information and reliably assign the different peaks to the corresponding isomers. 411 
3.4 Mouse serum sample 412 
To further asses the ability of the established method to separate isomeric 413 
glycoconjugates in biological samples, we measured the drift time of mTf glycans 414 
purified from serum samples. Only the analysis of the released glycans by IM-MS was 415 
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included in this study, as it was found to be the most sensitive and straightforward 416 
approach to obtain information about isomeric forms. Two serum samples were 417 
analysed: one healthy control and one sample with collagen-induced arthritis (CIA), an 418 
autoimmune disease known to alter the glycosylation pattern of mTf [51,58]. As can be 419 
seen in Figure 4, two peaks were observed for H5N4S2 glycan and three peaks for 420 
H6N5S3 in both samples, with the same drift time and similar relative intensities as in 421 
the mTf standard (compare Figure 4 with supplementary Figure S3). Although 422 
additional samples are required to observe possible differences in the relative abundance 423 
of glycan isomers between control and pathological samples, the presented 424 
methodology shows great potential for the separation of isomeric glycans and the 425 
discovery of novel biomarkers in glycomic studies.  426 
 427 
4. Concluding remarks 428 
In the present paper, the capability of IM-MS to separate isomeric glycoconjugates 429 
which are due to different types of sialic acid linkage (i.e. Į2-3 and Į2-6) has been 430 
evaluated at three different levels: intact glycoprotein, glycopeptides, and the released 431 
glycans. Separation of isomeric glycoconjugates is an important task in the glycomics 432 
field, because it has been reported that differences in the abundance of some glycan 433 
isomers might be of great importance for the early diagnosis or control of, for instance, 434 
inflammatory diseases and certain types of cancer.  435 
With our current knowledge of glycosylation effects on molecule size, and the limited 436 
ability of Synapt IM-MS instrumentation to resolve small CCS differences, isomeric 437 
separation cannot be obtained at the intact glycoprotein and glycopeptide level. 438 
Released glycans however can be separated after optimization of the IM parameters. As 439 
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stated before by others [15,45], and also demonstrated in this work, there is a 440 
workaround to distinguish different types of sialic acid linkage in glycopeptides that 441 
takes into account the mobility of an MS/MS fragment which still retains the sialic acid. 442 
This method can however be time-consuming and rather difficult, as glycopeptides must 443 
be separated from the rest of the digest and, besides, the obtained glycopeptide fragment 444 
is, actually, a glycan. 445 
The interest in using ion mobility for glycoconjugate separation and identification has 446 
seen a major growth in the last years. Thus, it is likely that new technologies and 447 
improvements will become available soon, including the advent of ion mobility 448 
instrumentation with up to ten times higher resolution. Therefore, the separation of 449 
sialic acid linkage isomers may also become possible at the level of glycopeptides and 450 
intact proteins in the future. 451 
 452 
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Figure legends 658 
 659 
Figure 1: Mass spectra showing the ion with charge +19 and the corresponding drift 660 
time (arrival time) distributions, or ATD, of a) intact mTf and b) intact hTf; and also c) 661 
ions with charge +13, +12 and +11 of intact hAGP and the corresponding ATD. The 662 
value indicated corresponds to the approximate glycosylation percentage (w/w) of each 663 
protein, calculated as the mass of the most abundant glycan per glycosylation site 664 
divided by the mass of the glycoprotein. i)-v): indicates the glycoform or the region of 665 
the mass spectrometric peak. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic 666 
acid (in this case, all S are N-glycolylneuraminic acid). The voltages for spray capillary, 667 
sampling cone, trap collision energy (CE), trap direct current (DC) bias and transfer CE 668 
were, respectively: 1.4-1.6 kV, 30 V, 4 V, 40 V and 0 V. 669 
 670 
Figure 2: a) MS/MS spectrum for the mTf glycopeptide glycoform 671 
N(H5N4S2)STLCDLCIGPLK; b) mass spectra of a fragment that still keeps the sialic 672 
acid (H1N1S1) and c) arrival time distribution of this fragment (m/z range: 673.3-673 
673.5). The symbols used for the representation of the glycoform H5N4S2 follow the 674 
Symbol Nomenclature for Glycans (SNFG) rules [59]. H: hexose; N: N-675 
acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are N-glycolylneuraminic 676 
acid). The voltages for spray capillary, sampling cone, trap collision energy (CE), trap 677 
direct current (DC) bias and transfer CE were, respectively: 1.5-1.7 kV, 50 V, 4 V, 20 V 678 
and 60 V. 679 
 680 
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Figure 3: Arrival time distributions for the H5N4S2 glycan released from mTf at 681 
different wave height (WH, in V) and wave velocity (WV, in m s-1) combinations. The 682 
symbols used for the representation of the H5N4S2 glycan follow the Symbol 683 
Nomenclature for Glycans (SNFG)  rules [59]. H: hexose; N: N-acetylhexosamine; F: 684 
fucose; S: sialic acid (in this case, all S are N-glycolylneuraminic acid). The voltages for 685 
spray capillary, sampling cone, trap collision energy (CE), trap direct current (DC) bias 686 
and transfer CE were, respectively: 1.5 kV, 50 V, 4 V, 45 V and 0 V. 687 
 688 
Figure 4: Arrival time distributions for the glycans a) H5N4S2 and b) H6N5S3 released 689 
from mTf in a healthy mouse serum and a serum from a mouse with collagen-induced 690 
arthritis (CIA). The symbols used for the glycan representation follow the Symbol 691 
Nomenclature for Glycans (SNFG)  rules [59]. H: hexose; N: N-acetylhexosamine; F: 692 
fucose; S: sialic acid (in this case, all S are N-glycolylneuraminic acid). The voltages for 693 
spray capillary, sampling cone, trap collision energy (CE), trap direct current (DC) bias 694 
and transfer CE were, respectively: 1.5 kV, 50 V, 4 V, 45 V and 0 V. 695 
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ABSTRACT 24 
The study of protein glycosylation can be regarded as an intricate but very important 25 
task, making glycomics one of the most challenging and interesting, albeit under-26 
researched, W\SH RI ³omics´ science. Complexity escalates remarkably when 27 
considering that carbohydrates can form severely branched structures with many 28 
different constituents, which often leads to the formation of multiple isomers. In this 29 
regard, ion mobility (IM) spectrometry has recently demonstrated its power for the 30 
separation of isomeric compounds. In the present work, the potential of traveling wave 31 
IM (TWIMS) for the separation of isomeric glycoconjugates was evaluated, using 32 
mouse transferrin (mTf) as model glycoprotein. Particularly, we aim to assess the 33 
performance of this platform for the separation of isomeric glycoconjugates due to the 34 
type of sialic acid linkage, at the intact glycoprotein, glycopeptide and glycan level. 35 
Straightforward separation of isomers was achieved with the analysis of released 36 
glycans, as opposed to the glycopeptides which showed a more complex pattern. 37 
Finally, the developed methodology was applied to serum samples of mice, to 38 
investigate its robustness when analysing real complex samples. 39 
 40 
41 
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1. Introduction 42 
Glycosylation is by far one of the most common and complex posttranslational 43 
modifications, with more than half of all secretory and cellular proteins being 44 
glycosylated [1±3]. Carbohydrates enhance the functional diversity of proteins, but they 45 
can also define their destination or elicit an immune response. The presence of glycans 46 
in the surface of eukaryotic cells is vital, as they take part in important cellular events, 47 
such as cell±cell interactions and receptor recognition [4]. Notwithstanding its 48 
importance and the major role of glycosylation in a multitude of biological processes 49 
[5±7], the analysis and characterization of carbohydrates is usually difficult due to their 50 
inherent complexity - the main reason why advances in glycomics have been scarcer 51 
compared to other ³omicV´ sciences [8,9]. Very often, in contrast to more linearly 52 
assembled biological molecules such as proteins or oligonucleotides, carbohydrates can 53 
form complex structures, severely branched, with many monosaccharide constituents, 54 
which usually results in a multitude of isomers [10]. 55 
Mass spectrometry (MS)-based techniques are the prime option for the characterization 56 
of glycoproteins, as reliable structural information can be obtained [7,11]. MS is 57 
frequently used in conjunction with chromatographic or electrophoretic separation 58 
techniques, as this allows high sensitivity profiling and accurate characterisation of 59 
heterogeneous glycan structures [12±14]. However, when analysing isomeric glycan 60 
structures, MS often fails to separate them [8,15±17], as they have identical mass and 61 
atomic composition. Some authors have suggested alternative strategies to separate 62 
isomeric glycoconjugates based on their derivatization,  or the use of capillary 63 
electrophoresis (CE) or hydrophilic interaction liquid chromatography (HILIC) - thus 64 
they remain undistinguishable unless derivatization or less common stationary phases in 65 
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liquid chromatography (LC) are used [18±23]. But even then, derivatization protocols 66 
can be time-consuming, expensive or hinder the ionization of some glycans, or, in the 67 
case of LCCE or HILIC, the unambiguous identification is still impossible when 68 
different isomers coelute. Moreover, in the last few years, several tandem mass 69 
spectrometry (MS/MS) methods have been reported that allow the identification of 70 
glycan isomers and the characterization of their structure [24±26]. However, few 71 
authors have studied the fragmentation of glycans with different sialic acid linkages. 72 
Even then, distinguishing by MS/MS between isomeric glycans due to sialic acid 73 
linkage is not trivial and, quite often, is based on differences in the relative abundance 74 
of certain fragment ions [27,28]. Therefore, a straightforward technique that helps to 75 
separate and differentiate those isomeric compounds is much needed. 76 
In this regard, ion-mobility (IM) spectrometry coupled with MS has aroused some 77 
interest in the last years, not only in the glycomics field but also in other omics sciences, 78 
as a proficient analytical technique for the separation of isomeric compounds 79 
[3,8,10,15±17,29±31]. Ion mobility provides an additional dimension for the separation 80 
of compounds, where ions are not only separated due to their mass and charge, but also 81 
on the basis of their shape and size - thereby resolving ions that would be otherwise 82 
indistinguishable solely by MS, such as, for instance, isomers [32±36]. Particularly, IM 83 
measures the time (drift time) that a particular ion takes to cross a cell filled with an 84 
inert, neutral background gas (N2 and He are most commonly used) at a controlled 85 
pressure under the influence of a weak electric field. The drift time of a specific ion is 86 
mainly due to ion-gas collisions; therefore, ions are separated due to their ion-neutral 87 
collision cross-section (ȍUHODWHGWRWKHRYHUDOOVKDSHDQGWRSRORJ\RIWKHLRQ [32±36]. 88 
Small compact ions have the shortest drift times, i.e. they arrive first, as a result of their 89 
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VPDOOHU ȍ 0RUHRYHU WKH KLJKHU WKH FKDUJH RI WKH LRQ WKH JUHDWHU WKH accelerating 90 
electric force, and therefore the more quickly the ion will cross the chamber. 91 
Consequently, the drift time of an ion is often described as being determined by the 92 
collision cross-section-to-FKDUJHUDWLRȍ] [35]. When coupled on-line with MS (IM-93 
MS), ion mobility provides three-dimensional analytical information for each detected 94 
species, i.e. shape-to-charge, mass-to-charge and abundance, thus allowing reliable 95 
analyte identification. 96 
Nowadays, there are several IM methods next to the classical drift-time ion mobility 97 
spectrometry (DTIMS), such as field asymmetric waveform ion mobility spectrometry 98 
(FAIMS), but among them, traveling wave ion mobility spectrometry (TWIMS) is the 99 
one that has seen a major growth in the last years [37,38]. In TWIMS, ions are propelled 100 
thanks to a sequence of symmetric potential waves continually propagating through a 101 
cell, each ion with its own velocity, thus different species transit the cell in different 102 
times. One of the main advantages of TWIMS is that it disperses ion mixtures, allowing 103 
the simultaneous measurement of multiple species. This, in conjunction with a high 104 
sensitivity obtained when TWIMS is coupled to certain analyzers in MS, such as time-105 
of-flight (TOF), has made this platform an alluring option for structural analysis and 106 
isomer separation [38±40]. This platform, along with other IM methods, have been 107 
recently explored for the analysis of glycans or glycoconjugates by several authors 108 
[8,15,16,41±47].  109 
In this work, TWIMS combined with TOF-MS was used for the study of 110 
glycoconjugate isomers which differ in the type of sialic acid linkage, with mouse 111 
transferrin (mTf) as a model glycoprotein. Sialic acid, an important monosaccharide 112 
residue of complex type N-glycans, may form primarily two types of linkages: Į-2o-3 113 
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or Į-2o-6. We aim to assess the capacity of TWIMS-TOF-MS (from now on referred 114 
to as IM-MS) as an analytical platform to separate Į-2o-3 DQG Į-2o-6 isomeric 115 
glycoconjugates at the intact glycoprotein, glycopeptide and glycan level. The 116 
developed methodology was also applied to serum samples of mice, to confirm its 117 
robustness when analysing real complex samples. 118 
  119 
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2. Materials and methods 120 
2.1 Chemicals 121 
All chemicals used in the preparation of buffers and solutions were of analytical reagent 122 
grade. Isopropanol (iPrOH), hydrochloric acid (HCl, 37% (w/v)), formic acid (FA, 98±123 
100%), ammonium acetate (NH4Ac, 98.0%) DQGJO\FLQH ZHUH VXSSOLHGE\124 
Merck (Darmstadt, Germany). CNBr-activated-Sepharose 4B was provided by GE 125 
Healthcare (Waukesha, WI, USA) and ³13-DOWHUQDWLYH´E\&DOELRFKHP (Darmstadt, 126 
Germany)6RGLXPFKORULGH1D&O'/-'LWKLRWKUHLWRO '77sodium 127 
cyanoborohydride (NaBH3CN), 2-PHUFDSWRHWKDQRO ȕ-ME), sodium dodecyl sulfate 128 
(SDS), iodoacetamide (IAA), ammonium hydrogencarbonate, sodium azide (NaN3, 129 
99.5%) water (LC-MS grade), acetonitrile (LC±MS grade) and mouse apotransferrin 130 
(mTf, reference: T0523) were supplied by Sigma±Aldrich (St. Louis, MO, USA) and 131 
7ULVK\GUR[\PHWK\ODPLQRPHWKDQH75,6E\-7%DNHU'HYHQWHU+ROODQG132 
Trypsin (Sequencing grade modified) was provided by Promega (Madison, WI, USA). 133 
RapiGest® from Waters (Bedford, MA, USA) was used to facilitate the enzymatic 134 
digestion. Goat polyclonal antibody against human transferrin (hTf) (immunogen 135 
affinity purified) was purchased from Abcam (Cambridge, UK). Human transferrin 136 
K7I DQG KXPDQ Į-1-acid glycoprotein (hAGP) were used as additional examples of 137 
other glycosylated glycoproteins and were also supplied by Sigma±Aldrich. 138 
2.2 Mice and induction of arthritis 139 
Wild-type (WT) mice were from Harlan Ibérica (Barcelona, Spain). All studies with live 140 
animals were authorized by the Institute of Parasitology and Biomedicine "López-141 
Neyra" (IPBLN) and Universidad de Cantabria Institutional Laboratory Animal Care 142 
8 
 
and Use Committees. For the induction of collagen-induced arthritis (CIA), 8-12 weeks-143 
old male mice were immunized as described elsewhere [48,49]. 144 
2.3 Purification of serotransferrin from mouse serum samples by immunoaffinity 145 
chromatography (IAC)  146 
In order to isolate mTf from the rest of serum proteins, an immunoaffinity (IA) 147 
purification was carried out using a cyanogen-bromide sepharose column where a 148 
polyclonal antibody against human transferrin (hTf) was bound, as detailed previously 149 
[50]. The IA procedure consisted of: first, a conditioning step with two washes of 10 150 
mM Tris-HCl; second, approximately 25 ɊL of serum were diluted 1:8 in 10 mM Tris-151 
HCl (pH 7.6-7.7) in order to improve antigen-antibody interaction, and passed through 152 
the column ten times. After washing with 10 mM Tris-HCl and 0.5 M NaCl (pH 7.6-153 
7.7), retained mTf was eluted with 100 mM glycine-HCl (pH 2.5). Eluted mTf was 154 
immediately neutralized with 0.5 M Tris. Afterwards, glycine-HCl buffer was 155 
exchanged for water by ultracentrifugation, using Microcon YM-10 (MW cut-off 10 156 
kDa, Millipore, Bedford, MA, USA). Then, samples were evaporated to dryness using a 157 
SpeedVacTM concentrator (Thermo Fisher Scientific, Waltham, MA, USA) and stored at 158 
-20ºC until use. Finally, the IA column was washed and stored in 10 mM Tris-HCl and 159 
0.01% (w/v) NaN3 (pH 7.6-7.7). 160 
2.4 Analytical approaches for mTf glycosylation study 161 
2.4.1 Intact glycoprotein analysis 162 
mTf standard ( ȝJ) was desalted using three different procedures: dialysis, size 163 
exclusion and ultracentrifugation. Briefly, in the first method, D-TubeTM dialyzers from 164 
Merck-Millipore were left in contact with 100 mM NH4Ac for 15 min. Afterwards, the 165 
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sample was placed into the dialyzer and left in contact with 500 mL of 100 mM NH4Ac 166 
for 2 h at 4ºC. Later, the buffer was renewed with 500 mL and the dialysis was allowed 167 
to continue for 2 more hours, repeating this process twice. Finally, the sample was 168 
carefully recovered and stored at -20ºC until analysis. Regarding the size exclusion 169 
procedure, the sample was desalted and the buffer exchanged using Micro Bio-SpinTM 170 
columns from BioRad (Hercules, California, USA) following the manufacturer 171 
instructions. Columns were centrifuged to remove the excess of packing buffer and 172 
washed three times with 500 ɊL of 100 mM NH4Ac. Finally, the sample was added and 173 
collected in a new tube after centrifugation. Lastly, the ultracentrifugation procedure 174 
was carried out using Microcon YM-10 (MW cut-off 10 kDa) to desalt and exchange 175 
the buffer of the sample. Filters were washed with 100 mM NH4Ac and centrifuged for 176 
10 min at 10000 g. Afterwards, the sample was added and washed with 50 ɊL of 100 177 
mM NH4Ac a total of 4 times, centrifuging each time for 10 min at 10000 g. Finally, the 178 
final volume was recovered in a new vial after centrifugation for 2 min at 1000 g, and 179 
reconstituted to the initial volume (25 ɊL). Centrifugation procedures were carried out 180 
in a MiniSpin® centrifuge (Eppendorf, Hamburg, Germany) at room temperature. In all 181 
cases, experiments with the standard glycoprotein were carried out in triplicate and 182 
intact mTf in 100 mM NH4Ac was injected directly into the mass spectrometer under 183 
non-denaturing conditions and detected in positive ion mode.  184 
2.4.2 Glycopeptide analysis 185 
mTf standard ( ȝJ) wasas reduced, alkylated and immediately subjected to trypsin 186 
digestion in the presence of RapiGest® as explained in a previous work [51]. Briefly, a 187 
solution of 0.5 M DL-dithiothreitol (DTT) in 50 mM NH4HCO3 was added to an aliquot 188 
of mTf with 0.1% (w/v) RapiGest®. The mixture was incubated at 56ºC for 30 min and 189 
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then alkylated with 50 mM iodoacetamide (IAA) for 30 min at room temperature in the 190 
dark. Excess reagent was removed by ultracentrifugation with Microcon YM-10 191 
columns (Millipore, Bedford, MA, USA). The final residue was recovered from the 192 
upper reservoir and reconstituted with NH4HCO3 buffer with 0.1% RapiGest®. Trypsin 193 
in a 1:40 ratio was added and the mixture was incubated overnight at 37ºC. Afterwards, 194 
the surfactant was hydrolyzed to avoid MS incompatibilities as follows: formic acid 195 
(FA) was added to the digest to a final concentration of 5% (v/v) and the mixture was 196 
incubated in the digester at 37ºC for 30 min. Then, the solution was centrifuged to 197 
separate RapiGest® residues. mTf tryptic digests were stored at -20ºC until analysis. All 198 
the experiments with the standard glycoprotein were carried out in triplicate. 199 
For the analysis of glycopeptides, a Waters Nano ACQUITY UPLC® was used with a 200 
double binary gradient pump, using a peptide BEH C18 column (1.7 µm particle 201 
diameter, 130 Å pore, 100 x 0.1 mm length x ID; Waters). Experiments were performed 202 
at room temperature with gradient elution at a flow rate of 400 nL min-1. Eluting 203 
solvents were A: water with 0.1% (v/v) of formic acid (FA), and B: acetonitrile with 204 
0.1% (v/v) FA. Solvents were degassed by sonication (10 min) before use. The 205 
optimum elution program was: solvent B from 10 to 60% (v/v) within 20 min as linear 206 
gradient, followed by cleaning and re-equilibration steps of B: 60 to 100% (v/v) (5 207 
min), 100% (v/v) (5 min), 100 to 10% (v/v) (5 min) and 10% (v/v) (5 min). Before 208 
analysis, samples were filtered using a 0.22 Ɋm polyvinylidene difluoride centrifugal 209 
filter (Ultrafree-MC, Millipore, Bedford, MA, USA) centrifuging at 10,000 g for 4 min. 210 
Sample injection (300 nL) was performed with an autosampler refrigerated at 4ºC. 211 
Control of the instrument was performed using MassLynx 4.1 (Waters).  212 
2.4.3 Glycan analysis 213 
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IAC purified mTf or mTf standard (25 Ɋg) was reduced with 0.5% 2-mercaptoethanol 214 
(ȕ-ME) and 0.5% SDS and subjected to enzymatic digestion with PNGase F as 215 
described in.IAC purified mTf or mTf standard (25 Ɋg) was reduced with 0.5% 2-216 
mercaptoethanol (ȕ-ME) and 0.5% SDS in 50 mM NH4HCO3 (pH 7.6-7.7) and heated 217 
in a thermo  block at 100 ºC for 30 min [19]. Once the sample was at room temperature, 218 
a volume of 50 mM NH4HCO3 (pH 7.6-7.7) with 1% (v/v) of NP-40 alternative was 219 
DGGHGWRREWDLQDILQDOFRQFHQWUDWLRQRI6'6DQGȕ-ME in the sample. To release 220 
the N-JO\FDQVȝ/RI31*DVH)8VROXWLRQZDVDGGHGWRWKHPL[WXUHZKLFKZDV221 
afterwards incubated at 37ºC for 18 h. Digestion was stopped by heating the sample in a 222 
thermo block at 100ºC for 5 min. AfterwardsThen, released glycans were isolated by 223 
solid phase extraction (SPE) using Hypercarb cartridges (25 mg, 1 mL volume, Thermo 224 
Fisher Scientific) and, subsequently, purified by ice-cold acetone precipitation 225 
following the procedure reported in [19] in both cases. Reduced glycans were diluted 226 
with 50:50 H2O/ACN with 0.1% FA and directly analyzed by IM-MS in negative ion 227 
mode. All the experiments with the standard glycoprotein were carried out in triplicate. 228 
Mice derived transferrin glycan analysis was carried out in duplicate, including 229 
purification and release of glycans. 230 
2.5 Ion mobility-mass spectrometry 231 
For IM-MS analysis a Synapt G2 HDMS instrument from Waters was used. Samples 232 
were directly introduced into the vacuum of the mass spectrometer using home-made 233 
nano-electrospray ionization (nano-ESI) gold-coated borosilicate capillaries;, unless 234 
when analysed by nano-UPLC-IM-MS, in which case an in-line nano-ESI interface with 235 
commercially available coated needles was used. 236 
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Spectra were acquired in positive mode for the analysis of intact glycoproteins and 237 
glycopeptides, and in negative mode for glycans, and conditions were optimized in each 238 
case. The voltages for spray capillary, sampling cone, trap collision energy (CE), trap 239 
direct current (DC) bias and transfer CE were, respectively: intact glycoproteins, 1.4-1.6 240 
kV, 30 V, 4 V, 40 V and 0 V; glycopeptides, 1.5-1.7 kV, 50 V, 4 V, 20 V and 0 V; and 241 
glycans, 1.5 kV, 50 V, 4 V, 45 V and 0 V. 7KH³Wrap CE´YROWDJH was only increased to 242 
60 V when fragmentation of the glycopeptides was the goal. Mass spectrometer control 243 
and spectra processing were carried out using MassLynx 4.1 (Waters). 244 
The software IMoS [52,53], available for free at imospedia.com, was used for the 245 
theoretical calculations of the collision cross sections (CCS) of glycans, using their 246 
minimum energy structures. The online tool carbohydrate builder, available at 247 
glycam.org [54], was used to generate the required input for theoretical calculations. 248 
The tool allows building different glycan isomers based on monosaccharide unit and 249 
linkage type, and generates minimum energy structures.  250 
  251 
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3. Results and discussion 252 
3.1 Intact glycoprotein analysis 253 
It is well established that intact proteins can be analysed mainly in two different ways 254 
when using electrospray ionization: under denaturing or non-denaturing (i.e., ³native´) 255 
conditions. In the first case, the protein appears highly charged with a broad charge state 256 
distribution; thus, the separation of the different glycoforms is difficult. On the other 257 
hand, an advantage of native MS is that it strongly reduces charging, hence the different 258 
glycoforms can be more clearly resolved [55]. 259 
Using native MS in this work, the concentration of ammonium acetate and the nano-ESI 260 
source parameters were optimized to improve and obtain the best possible sensitivity 261 
and separation between mTf glycoforms in positive ion mode. Moreover, in order to 262 
obtain an acceptable separation between the several glycoforms, mTf was washed 263 
repeatedly with 100 mM NH4Ac to eliminate excipients and salts, and injected directly 264 
into the mass spectrometer without further separation. Without washing, no glycoform 265 
separation was observed whatsoever. Three methods were evaluated to desalt the 266 
glycoprotein: dialysis, size exclusion and ultracentrifugation, with the latter one giving 267 
the best results (see supplementary Figure S1). Afterwards, the drift times of intact 268 
glycoforms were determined by ion mobility. In Figure 1-a, the ion with charge +19 of 269 
mTf is shown, as well as the arrival time distributions (ATD) of different sections of 270 
this peak (Figure 1-a (i-v)), each corresponding to one intact glycoform of mTf). As can 271 
be observed in the ATD profiles, only one, relatively wide peak is obtained for each 272 
glycoform. Hence, these results imply that, at least for large glycoproteins with a low 273 
degree of glycosylation, the glycan part has barely any influence on the overall size of 274 
the whole molecule as the CCS appears virtually unaffected by glycosylation. hTf and 275 
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hAGP were also studied to see if the same behaviour was observed with other 276 
glycoproteins. Figure 1-b and 1-c show the separation between intact glycoforms in the 277 
MS spectra of hTf (for the ion with charge +19) and hAGP, respectively. As can be 278 
observed, the peak was better resolved for hTf, but no separation was observed for 279 
hAGP, as the number of glycoforms was considerably higher and the overlapping of 280 
several ion distributions was unavoidable. Moreover, one wide peak was observed again 281 
when the drift time of each section of the mass spectrum was measured for both 282 
glycoproteins. Regarding hTf, each section corresponded to one glycoform (Figure 1-b 283 
(i-iv)), whereas, in the case of hAGP, the resolution was not high enough to ensure that 284 
a selected region of the peak corresponded to one defined glycoform (Figure 1-c (i-v)), 285 
because of the high glycosylation degree of hAGP. The higher the m/z region of this 286 
peak however, the bigger the carbohydrate fraction is (usually meaning more complex 287 
and branched glycans). This is due to the fact that an increase of m/z within the same 288 
charge state can only be due to an increase in the number of glycan subunits of the 289 
carbohydrate fraction, as the polypeptide backbone remains unaltered. For the sake of 290 
consistency, we will refer to each section of the peak as glycoform, even if, as in the 291 
case of hAGP, they are not resolved. Interestingly, the drift time increased with 292 
increasing carbohydrate fraction, i.e. complexity and branching of the glycoforms, in all 293 
three cases (see Figure 1-a (i-v), 1-b (i-iv) and 1-c (i-v), type of glycoform indicated 294 
where possible). The relative drift time differences between glycoforms were higher in 295 
proteins with higher glycosylation content, as can be observed for hAGP (see Figure 1-296 
c). Moreover, if we compare the drift time between different glycoforms of mTf and 297 
hTf, the increase in drift time was more noticeable in hTf, as the percentage of 298 
glycosylation is slightly higher here in relation to the total protein mass. As Table 1 299 
shows, for the same relative increase in m/z, the relative drift time increase is higher for 300 
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hAGP, which demonstrates that for glycoproteins with a high percentage of 301 
glycosylation, differences in the glycosylation have a greater effect on the drift time of 302 
the whole molecule (i.e., they significantly alter the CCS of the whole glycoprotein). It 303 
could then also be conceivable to separate isomers due to the different sialic acid 304 
linkage (of the same glycoform) at the intact protein level if the glycan:peptide ratio was 305 
high enough. However, this option would not have been viable for all types of 306 
glycoproteins, thus, other alternatives were studied. 307 
3.2 Glycopeptide analysis 308 
As mTf only shows one glycosite at asparagine 494, only one glycopeptide is expected 309 
after tryptic digestion (N494 glycopeptide, peptide: NSTLCDLCIGPLK). However, with 310 
the direct injection of the digest, the N494 glycopeptide was not detected, hence, an 311 
additional separation before the MS was mandatory. In this regard, nano-UPLC was 312 
used as a separation technique prior to IM-MS detection, in order to separate the 313 
glycopeptide from the other peptides and simultaneously determine the drift time of the 314 
different glycoforms. Injection volume, flow rate and gradient were optimized to obtain 315 
the best sensitivity with a stable spray (see section 2.4, Materials and Methods). Table 2 316 
shows the detected glycoforms at the peptide level, their theoretical and experimental 317 
masses, mass error and observed charge states.  318 
Regarding the determination of the drift time of the different glycopeptide glycoforms, 319 
even though a range of different values for the wave velocity (WV) and wave height 320 
(WH) of the TWIMS device were tested, only one drift time value was observed. This 321 
suggests that no isomer separation was possible at this mobility resolution, which is 322 
probably due to the fact that the different isomers had similar CCS despite the distinct 323 
orientation of the sialic acid. Recently, Hinneburg et al. [15] and Guttman et al. [45] 324 
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also described this observation analysing glycopeptides directly by IM-MS. They 325 
observed no isomeric separation, unless fragmentation of the glycopeptide was carried 326 
out and one of the observed smaller fragments still contained the sialic acid. This 327 
fragment (obtained before the IM cell) had different drift times depending on the sialic 328 
acid linkage, because a change in the orientation of the sialic acid was more noticeable 329 
(i.e. the CCS was more affected) in a smaller analyte. We also tested this approach, by 330 
fragmenting the most intense glycopeptide glycoform (N(H5N4S2)STLCDLCIGPLK) 331 
before the IM cell. Figure 2-a shows the collision induced dissociation (CID) MS/MS 332 
spectrum for this glycoform. Several fragments were obtained, e.g., the 333 
glycolylneuraminic acid (S1) and H1N1 and H2N1 fragments. Among all the fragments 334 
however, H1N1S1 was the one that still retained the sialic acid linkage and had enough 335 
intensity to yield a good and accurate drift time measurement. Isomer separation was 336 
observed in the aforementioned glycan fragment. Specifically, as it is shown in Figure 337 
2-c, two drift time peaks were clearly observed at this m/z, which are postulated to be 338 
due to the sialic acid being Į-2-o6 and Į-2o-3 linked. To confirm that the sialic acid is 339 
the monosaccharide that affects the CCS of the fragment the most, the ATD of the 340 
fragment H1N1 is shown in supplementary Figure S2-c. In this case, we only observed 341 
one drift time, which demonstrates that it is the sialic acid which causes observable CCS 342 
differences seen as two different drift times of the fragment H1N1S1.  343 
Moreover, in order to confirm that the distinct drift times observed for the glycan 344 
fragment could be due to different sialic acid linkages, the theoretical CCS of the 345 
H1N1S1 isomers were calculated. The obtained CCS values can be found in Table 3. 346 
were: 233.4 Å2 IRUWKHĮ-2o6 linkage and 243.7 Å2 IRUWKHĮ-2o3 glycan, The CCS for 347 
the two H1N1S1 were different enough to be separated by IM. Taking into account the 348 
17 
 
CCS values of Table 3, This suggests that the more prominent, lower drift time peak 349 
(i.e., lower CCS) should corresponds to the Į-2o-6 glycan, whereas the second peak 350 
represents the Į-2o-3 glycan. 351 
Our results are in accordance with those obtained by Hinneburg et al. [15], who, using 352 
modelling, drew the same conclusions. This is also in agreement with Guttman et al. 353 
[45], who found that biantennary glycoforms showed lower content of Į-2o-3 354 
sialylation. In our case, the percentage of Į-2-o3 glycan was approximately 14% 355 
(taking into account the measured area of each drift time peak, see Figure 2-c). 356 
However, this ratio can vary depending on the glycoprotein studied [45]. With this 357 
method, using nano-UPLC-IM-MS and drift time measurement of the MS/MS 358 
fragments, separation of glycopeptide isomers was achieved.This glycopeptide 359 
approach, through the analysis of the fragment H1N1S1, gave valuable information 360 
about the content of each type of sialic acid as the fragment H1N1S1 came from both 361 
branches of the H5N4S2 glycopeptide (we did not detect any fragment with only one 362 
antenna remaining (H3N3 or H3N3S1), suggesting that both antennas might indeed be 363 
fragmented). This relevant information could permit, in the future, to correlate changes 364 
in protein sialylation with specific disease biomarkers which involve protein 365 
glycosylation, such as, e.g., in cancer or inflammation. 366 
 367 
3.3 Glycan analysis 368 
Finally, we proceeded with the study of the enzymatically released glycans using 369 
PNGase F. Different solvents were tested to obtain the best spray and ionization yield, 370 
and a slightly superior glycan signal was obtained at 50:50 H2O:ACN with 0.1% FA. 371 
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Table 3 4 shows the detected mTf glycans along with their theoretical and experimental 372 
masses, mass error and observed charge states. In Figure 3 the ATD profile of H5N4S2 373 
glycans at different values of WV and WH is shown. Two peaks are observed which are 374 
believed to correspond to two different isomers of the glycan H5N4S2, in analogy to the 375 
previously obtained results (Figure 2-c) with the fragment H1N1S1 of the glycopeptide 376 
N(H5N4S2)STLCDLCIGPLK. Fine tuning of the IM parameters was mandatory in 377 
order to resolve both drift time peaks. A WV value of 450 m s-1 and WH of 25 V was 378 
selected as optimal for the analysis of all mTf glycans. It is worth mentioning that in 379 
this case, glycans were analyzed in negative mode and, as can be observed in Figure 3, 380 
the first isomer was clearly the less abundant one. This is in contrast to the glycopeptide 381 
analysis which was done in positive mode, where the less abundant isomer was the 382 
second one. This could be due to the fact that both molecules were, actually, quite 383 
different - specifically, the glycan had eleven monosaccharide units, as opposed to the 384 
fragment observed in the glycopeptide analysis which had only three. With regard to 385 
other glycans, three different peaks, i.e., three drift times, were observed for H6N5S3 386 
(see supplementary Figure 2S3-c), albeit separation was slightly worse than observed 387 
for H5N4S2. H5N4S1 on the other hand only showed one wide peak (see 388 
supplementary Figure 2S3-d), most probably implying that only one glycan isomer 389 
exists or that the different isomers have similar CCS, and IM is not able to distinguish 390 
them (as. However, the absence of other drift time peaks does not preclude the presence 391 
of other isomers)., as they can have similar CCS. It is also worth pointing out that when 392 
the glycan contained a fucose unit, the isomeric separation was somewhat hampered, as 393 
observed in supplementary Figure 2S3-b. We reckon that the addition of one extra 394 
monosaccharide unit might affect the global CCS of the glycan, and as the whole glycan 395 
is bigger, a small variation in the orientation of the sialic acid is less noticeable.  396 
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To confirm that separation of isomeric glycans due to the sialic acid linkage was also 397 
possible with other glycoproteins, hAGP was also digested with PNGase F and the 398 
released glycans analysed by IM-MS. Separation of isomeric glycans was achieved, 399 
seemingly obtaining the same results as with mTf. As an example, the arrival time 400 
distributions of the H5N4S2 and H6N5S2 glycans are shown in supplementary Figure 401 
3S4. As can be seen, two drift time peaks were obtained for the H5N4S2 glycan and 402 
three peaks for H6N5S3, albeit separation was poorer in both cases when compared to 403 
mTf.  404 
Moreover, to confirm that ion mobility separation of these possible isomers is due to 405 
different sialic acid linkages, Table 3 shows the theoretical CCS values of the four 406 
possible isomers for the glycan H5N4S2 with (ɲ-2o3)2, (ɲ-2o6) and (ɲ-2o3), (ɲ-26) 407 
nd (ɲ-2o3) and (ɲ-2o6)2 sialic acids were calculated. The obtained CCS were, 408 
following the same order: 652.3 Å2 for the (ɲ-2o3)2 glycan, 635.4 Å2 for (ɲ-2o6)(ɲ-409 
2o3), xxx Å2 and 623.9 Å2 for the (ɲ-2o6)2 form. The differences between these 410 
calculated values suggest that the observed ion mobility peaks could be due to isomeric 411 
glycans with different types of sialic acid linkage. With the knowledge of theoretical 412 
CCS, and the DEXQGDQFHRIWKHĮ-2-o3 H1N1S1 fragment being lower than the Į-2o-6 413 
(based on fragmentation of the H5N4S2 glycopeptide, see above), the two peaks 414 
observed for the H5N4S2 glycan were tentatively assignedsome conclusions can be 415 
drawn. We reckon that the presence of the isomer with two sialic acids Į2-3 can be 416 
discarded and that the two peaks observed must correspond to the isomers with higher 417 
content in Į2-6, that is, the isomer with two sialic acids Į2-6 and the isomer with one 418 
sialic acid Į2-6 and one Į2-3 (although we cannot specify the branch where each sialic 419 
acid is located).We suggest that the peak with the highest drift time, and highest 420 
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abundance, could be the glycan (ɲ-2o6)(ɲ-2o3) linkage, however, we cannot specify 421 
the branch where each sialic acid is locatedbound. Whereas, the one with the lowest 422 
drift time (and lowest abundance) could be the (ɲ-2o6)2-linked glycan. However, 423 
Aalternative approaches for the study of isomeric glycoconjugates, for instance using 424 
specific sialidases [18], could would however be allow to useful to obtain 425 
complementary information and reliably assign the different isomerspeaks to the 426 
corresponding isomers. 427 
3.4 Mousice serum sample 428 
To further asses the ability of the established method to separate isomeric 429 
glycoconjugates in biological samples, we measured the drift time of mTf glycans 430 
purified from serum samples. Only the analysis of the released glycans by IM-MS was 431 
included in this study, as it was found to be the most sensitive and straightforward 432 
approach to obtain information about isomeric forms. Two serum samples were 433 
analysed: one healthy control and one sample with collagen-induced arthritis (CIA), an 434 
autoimmune disease known to alter the glycosylation pattern of mTf [51,58]. As can be 435 
seen in Figure 4, two peaks were observed for H5N4S2 glycan and three peaks for 436 
H6N5S3 in both samples, with the same drift time and similar relative intensities as in 437 
the mTf standard (compare Figure 4 with supplementary Figure 2S3). Although 438 
additional samples are required to observe possible differences in the relative abundance 439 
of glycan isomers between control and pathological samples, the presented 440 
methodology shows great potential for the separation of isomeric glycans and the 441 
discovery of novel biomarkers in glycomic studies.  442 
 443 
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4. Concluding remarks 444 
In the present paper, the capability of IM-MS to separate isomeric glycoconjugates 445 
which are due to different types of sialic acid linkage (i.e. Į-2o-3 and Į-2o-6) has 446 
been evaluated at three different levels: intact glycoprotein, glycopeptides, and the 447 
released glycans. Separation of isomeric glycoconjugates is an important task in the 448 
glycomics field, because it has been reported that differences in the abundance of some 449 
glycan isomers might be of great importance for the early diagnosis or control of, for 450 
instance, inflammatory diseases and certain types of cancer.  451 
With ourthe current knowledge of glycosylation effects on molecule size, and the 452 
limited abilitycapabilities of Synapt IM-MS instrumentation to resolve small CCS 453 
differences, isomeric separation cannot be obtained at the intact glycoprotein and 454 
glycopeptide level. Released glycans however can be separated after optimization of the 455 
IM parameters. As stated before by others [15,45], and also demonstrated in this work, 456 
there is a workaround to distinguish different types of sialic acid linkage in 457 
glycopeptides that takes into account the mobility of an MS/MS fragment which still 458 
retains the sialic acid. This method can however be time-consuming and rather difficult, 459 
as glycopeptides must be separated from the rest of the digest and, besides, the obtained 460 
glycopeptide fragment is, actually, a glycan. 461 
The interest in using ion mobility for glycoconjugate separation and identification has 462 
seen a major growth in the last years. Thus, it is likely that new technologies and 463 
improvements will become available soon, including the advent of ion mobility 464 
instrumentation with up to ten times higher resolution. Therefore, the separation of 465 
sialic acid linkage isomers may also become possible at the level of glycopeptides and 466 
intact proteins in the future. 467 
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Figure legends 674 
 675 
Figure 1: Mass spectra showing the ion with charge +19 and the corresponding drift 676 
time (arrival time) distributions, or ATD, of a) intact mTf and b) intact hTf; and also c) 677 
ions with charge +13, +12 and +11 of intact hAGP and the corresponding ATD. The 678 
value indicated corresponds to the approximate glycosylation percentage (w/w) of each 679 
protein, calculated as the mass of the most abundant glycan per glycosylation site 680 
divided by the mass of the glycoprotein. i)-v): indicates the glycoform or the region of 681 
the mass spectrometric peak. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic 682 
acid (in this case, all S are N-glycolylneuraminic acid). The voltages for spray capillary, 683 
sampling cone, trap collision energy (CE), trap direct current (DC) bias and transfer CE 684 
were, respectively: 1.4-1.6 kV, 30 V, 4 V, 40 V and 0 V. 685 
Figure 2: a) MS/MS spectrum for the mTf glycopeptide glycoform 686 
N(H5N4S2)STLCDLCIGPLK; b) mass spectra of a fragment that still keeps the sialic 687 
acid (H1N1S1) and c) arrival time distribution of this fragment (m/z range: 673.3-688 
673.5). The symbols used for the representation of the glycoform H5N4S2 follow the 689 
Consortium for Functional GlycomicsSymbol Nomenclature for Glycans (SNFG) 690 
(CFG) rules [59]. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this 691 
case, all S are N-glycolylneuraminic acid). The voltages for spray capillary, sampling 692 
cone, trap collision energy (CE), trap direct current (DC) bias and transfer CE were, 693 
respectively: 1.5-1.7 kV, 50 V, 4 V, 20 V and 60 V. 694 
Figure 3: Arrival time distributions for the H5N4S2 glycan released from mTf at 695 
different wave height (WH, in V) and wave velocity (WV, in m s-1) combinations. The 696 
symbols used for the representation of the H5N4S2 glycan follow the Symbol 697 
Nomenclature for Glycans (SNFG) Consortium for Functional Glycomics (CFG) rules 698 
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[59]. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are 699 
N-glycolylneuraminic acid). The voltages for spray capillary, sampling cone, trap 700 
collision energy (CE), trap direct current (DC) bias and transfer CE were, respectively: 701 
1.5 kV, 50 V, 4 V, 45 V and 0 V. 702 
Figure 4: Arrival time distributions for the glycans a) H5N4S2 and b) H6N5S3 released 703 
from mTf in a healthy mouse serum and a serum from a mouse with collagen-induced 704 
arthritis (CIA). The symbols used for the glycan representation follow the Symbol 705 
Nomenclature for Glycans (SNFG) Consortium for Functional Glycomics (CFG) rules 706 
[59]. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are 707 
N-glycolylneuraminic acid). The voltages for spray capillary, sampling cone, trap 708 
collision energy (CE), trap direct current (DC) bias and transfer CE were, respectively: 709 
1.5 kV, 50 V, 4 V, 45 V and 0 V. 710 
 711 
Figure S1: Mass spectra of the ion with charge +19 of intact mTf after desalting with 712 
three different methods: a) dialysis, b) size exclusion columns, and c) 713 
ultracentrifugation. The voltages for spray capillary, sampling cone, trap collision 714 
energy (CE), trap direct current (DC) bias and transfer CE were, respectively: 1.4-1.6 715 
kV, 30 V, 4 V, 40 V and 0 V. 716 
Figure S2: a) MS/MS spectrum for the mTf glycopeptide glycoform 717 
N(H5N4S2)STLCDLCIGPLK; b) mass spectra of a fragment that still keeps the sialic 718 
acid (H1N1) and c) arrival time distribution of this fragment (m/z range: 366.2-366.4). 719 
The symbols used for the representation of the glycoform H5N4S2 follow the Symbol 720 
Nomenclature for Glycans (SNFG) rules [59]. H: hexose; N: N-acetylhexosamine; F: 721 
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fucose; S: sialic acid (in this case, all S are N-glycolylneuraminic acid). The voltages for 722 
spray capillary, sampling cone, trap collision energy (CE), trap direct current (DC) bias 723 
and transfer CE were, respectively: 1.5-1.7 kV, 50 V, 4 V, 20 V and 60 V. 724 
 725 
Figure 2S3: Arrival time distributions for several glycans of mTf standard: a) H5N4S2, 726 
b) H5N4F1S2, c) H6N5S3 and d) H5N4S1. The symbols used for the glycan 727 
representation follow the Symbol Nomenclature for Glycans (SNFG) Consortium for 728 
Functional Glycomics (CFG) rules [59]. H: hexose; N: N-acetylhexosamine; F: fucose; 729 
S: sialic acid (in this case, all S are N-glycolylneuraminic acid). The voltages for spray 730 
capillary, sampling cone, trap collision energy (CE), trap direct current (DC) bias and 731 
transfer CE were, respectively: 1.5 kV, 50 V, 4 V, 45 V and 0 V. 732 
 733 
Figure 3S4: Arrival time distributions for a) H5N4S2 glycan and b) H6N5S3 glycan of 734 
hAGP. The symbols used for the glycan representation follow the Symbol 735 
Nomenclature for Glycans (SNFG) rules [59]Consortium for Functional Glycomics 736 
(CFG) rules. H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, 737 
all S are N-acetylneuraminic acid). The voltages for spray capillary, sampling cone, trap 738 
collision energy (CE), trap direct current (DC) bias and transfer CE were, respectively: 739 
1.5 kV, 50 V, 4 V, 45 V and 0 V. 740 
 741 
  742 
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Table 1: Relative increase in m/z and drift time between glycoforms i) and ii) (Figure 743 
1) of mTf, hTf and hAGP. 744 
 745 
* The relative m/z for hTf and hAGP was changed to have the same value as mTf 746 
(0.247 %) and, therefore, the relative drift time was proportionally modified. 747 
 748 
  749 
 mTf hTf hAGP 
Relative m/z difference (%) 0.247 0.239 0.746 
Relative drift time difference (%) 0.149 0.290 1.324 
Normalization* 
Relative m/z (%) 0.247 0.247 0.247 
Relative drift time (%) 0.149 0.299 0.438 
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Table 2: Theoretical and experimental molecular mass (Mr), mass error and detected 750 
charge states of the 10 glycoforms for the N494 glycopeptide of mTf detected by nano-751 
UPLC-IM-MS. 752 
 753 
* H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are N-754 
glycolylneuraminic acid) 755 
  756 
Glycopeptide Glycoform* Theoretical Mr 
Experimental 
Mr 
Mass 
error 
(ppm) 
Observed 
charge 
state 
N494 
H3N3S1 2892.2138 2892.2840 24 +2 
H3N3F1S1 3038.2717 3038.2920 7 +2 
H5N4S1 3419.3988 3419.3908 2 +2, +3 
H5N4F1S1 3565.4568 3565.4656 2 +3 
H5N4S2 3726.4892 3726.4993 3 +2, +3 
H5N4F1S2 3872.5471 3872.5600 3 +2, +3 
H5N4S3 4033.579 4033.6210 10 +2, +3 
H5N4F1S3 4179.6374 4179.6958 14 +2, +3 
H6N5S3 4398.7117 4398.7813 16 +3 
H6N5F1S3 4544.7696 4544.8321 14 +3 
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Table 3: CCS values of the two isomers for the fragment H1N1S1 and the four isomers 757 
for the H5N4S2 glycan. 758 
  
 Isomer CCS (Å2) 
Glycopeptide 
N494-H5N4S2 
Fragment 
 
H1N1S1 Į-6  
H1N1S1 Į-3  
Glycan 
H5N4S2 
3-antenna 
6-antenna 
Į-6 
Į-3 584.7 
[Į-6  
3-antenna 
6-antenna 
Į-3 
Į-6 635.4 
[Į-3 652.3 
  759 
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Table 34: Theoretical and experimental molecular mass (Mr), mass error and detected 760 
charge states of the 10 mTf glycans detected by IM-MS. 761 
 762 
 763 
* H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are N-764 
glycolylneuraminic acid) 765 
 766 
 767 
 768 
 769 
 770 
Glycan* Theoretical Mr 
Experimental 
Mr 
Mass error 
(ppm) 
Observed 
charge state 
H3N3S1 1420.4975 1420.4659 22 -1 
H3N3F1S1 1566.5554 1566.5692 9 -1 
H5N4S1 1947.6825 1947.7031 11 -1 
H5N4F1S1 2093.7404 2093.7891 23 -1 
H5N4S2 2254.7729 2254.7650 4 -2 
H5N4F1S2 2400.8308 2400.8240 3 -2 
H5N4S3 2561.8632 2561.9150 20 -2 
H5N4F1S3 2707.9211 2707.9470 10 -2 
H6N5S3 2926.9954 2926.9334 21 -2, -3 
H6N5F1S3 3073.0533 3073.0036 16 -3 
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Table 1: Relative increase in m/z and drift time between glycoforms i) and ii) (Figure 
1) of mTf, hTf and hAGP. 
 
* The relative m/z for hTf and hAGP was changed to have the same value as mTf 
(0.247 %) and, therefore, the relative drift time was proportionally modified. 
 
  
 mTf hTf hAGP 
Relative m/z difference (%) 0.247 0.239 0.746 
Relative drift time difference (%) 0.149 0.290 1.324 
Normalization* 
Relative m/z (%) 0.247 0.247 0.247 
Relative drift time (%) 0.149 0.299 0.438 
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Table 2: Theoretical and experimental molecular mass (Mr), mass error and detected 
charge states of the 10 glycoforms for the N494 glycopeptide of mTf detected by nano-
UPLC-IM-MS. 
 
* H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are N-
glycolylneuraminic acid) 
  
Glycopeptide Glycoform* Theoretical Mr 
Experimental 
Mr 
Mass 
error 
(ppm) 
Observed 
charge 
state 
N494 
H3N3S1 2892.2138 2892.2840 24 +2 
H3N3F1S1 3038.2717 3038.2920 7 +2 
H5N4S1 3419.3988 3419.3908 2 +2, +3 
H5N4F1S1 3565.4568 3565.4656 2 +3 
H5N4S2 3726.4892 3726.4993 3 +2, +3 
H5N4F1S2 3872.5471 3872.5600 3 +2, +3 
H5N4S3 4033.579 4033.6210 10 +2, +3 
H5N4F1S3 4179.6374 4179.6958 14 +2, +3 
H6N5S3 4398.7117 4398.7813 16 +3 
H6N5F1S3 4544.7696 4544.8321 14 +3 
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Table 3: CCS values of the two isomers for the fragment H1N1S1 and the four isomers 
for the H5N4S2 glycan. 
  
 Isomer CCS (Å2) 
Glycopeptide 
N494-H5N4S2 
Fragment 
 
H1N1S1 Į-6 233.4 
H1N1S1 Į-3 243.7 
Glycan 
H5N4S2 
3-antenna 
6-antenna 
Į-6 
Į-3 584.7 
[Į-6 623.9 
3-antenna 
6-antenna 
Į-3 
Į-6 635.4 
[Į-3 652.3 
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Table 4: Theoretical and experimental molecular mass (Mr), mass error and detected 
charge states of the 10 mTf glycans detected by IM-MS. 
 
 
* H: hexose; N: N-acetylhexosamine; F: fucose; S: sialic acid (in this case, all S are N-
glycolylneuraminic acid) 
 
 
 
 
 
 
Glycan* Theoretical Mr 
Experimental 
Mr 
Mass error 
(ppm) 
Observed 
charge state 
H3N3S1 1420.4975 1420.4659 22 -1 
H3N3F1S1 1566.5554 1566.5692 9 -1 
H5N4S1 1947.6825 1947.7031 11 -1 
H5N4F1S1 2093.7404 2093.7891 23 -1 
H5N4S2 2254.7729 2254.7650 4 -2 
H5N4F1S2 2400.8308 2400.8240 3 -2 
H5N4S3 2561.8632 2561.9150 20 -2 
H5N4F1S3 2707.9211 2707.9470 10 -2 
H6N5S3 2926.9954 2926.9334 21 -2, -3 
H6N5F1S3 3073.0533 3073.0036 16 -3 
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